Your Article Summary
See Latest ArticlesInterferon-beta Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?
Journal of Neurological Sciences (Turkish), 06/22/09
Kurne A et al. - This study evaluates the two MS subgroups that are not in the range of expected age profiles (<20 and >40 years old patients). Although increasing evidence suggests a slower disease course in children with MS when compared to adults, significant disability can still accumulate by early adulthood. There are controversial reports regarding the prognosis of late onset MS patients...In this study, the response to IFN therapy in young onset MS patients has been found similar to older age onset MS patients.
Related Articles
Early Psychiatric Manifestation in a Patient with Primary Progressive Multiple Sclerosis
Archives of Iranian Medicine, 11/12/09
Relevance Score: 69%
Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09
Relevance Score: 69%
A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09
Relevance Score: 69%
Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis
International Immunology, 10/14/09
Relevance Score: 68%
Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09
Relevance Score: 68%
Today in Neurologic/Ophthalmic...keeping you current
Receive free subspecialty "5-minute updates" via email
The regulatory role of the MisR/S two-component system in hemoglobin utilization in Neisseria meningitidis
Infection and Immunity, 12/18/09
Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
Journal of Neuroinflammation, 12/16/09
Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease
Journal of Neuroinflammation, 12/14/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09
Efficacy and Safety of Pentavalent Human-Bovine Reassortant Rotavirus Vaccine When Administered With Greater Than 10 Weeks Between Doses
The Pediatric Infectious Disease Journal, 12/17/09